Discover the X Factor in Wound Care
BlastX™ is an antimicrobial wound gel powered by Next Science’s patented, non-toxic Xbio™ technology. It deconstructs the bacterial biofilm EPS matrix, destroys bacteria within the gel, and defends from recolonization while maintaining a moist wound environment.
Others only address the tip of the iceberg.
See how the 3 Dimensions of BlastX
go deeper to solve the problem of
BlastX Supersedes Current Therapy by Reducing Biofilm Bacteria 4-6 Log in Laboratory Tests
In in vitro studies, BlastX was compared to multiple current topical antimicrobial therapies. 24 hours after application, measurements were taken for two different kinds of biofilm bacteria (S. aureus and P. aeruginosa). Compared to the other topical antimicrobials, BlastX significantly reduced the number of biofilm bacteria present by 4 to 6 log.24, 41
U.S. Consensus Paper Highlights the Importance of Biofilm Disruption in Treating Chronic Wounds
BlastX Antimicrobial Wound Gel is featured in “Wound Biofilm: Current Perspectives on Biofilm Disruption and Treatments” in WOUNDS®, a compendium of clinical research and practice. The peer-reviewed paper provides a new perspective regarding the need for a paradigm shift toward biofilm treatment strategies and disruption of the bacterial biofilm protective matrix.
BlastX™ is indicated for the management of wounds such as Stage I-IV pressure ulcers, partial- and full-thickness wounds, diabetic foot and leg ulcers, post-surgical wounds, first and second degree burns, and grafted and donor sites.
When applied to biofilm in vitro, BlastX™ has reduced the number of bacteria present by 4 to 6 log.24
For more information about how BlastX™ has performed in clinical studies, download the following publications:
Snyder RJ, Bohn G, Hanft J, Harkless L, Kim P, Lavery L, Schultz G, Wolcott R. Wound Biofilm: Current Perspectives and Strategies on Biofilm Disruption and Treatments. Wounds: a compendium of clinical research and practice. 2017 Jun;29(6):S1-S17.
Kim D, Namen W, Moore J, Buchanan M, Hayes V, Myntti M, Hakaim A. Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach. Wounds. Epub 2018 January 26.
BlastX™ is non-toxic and compatible with a broad range of advanced healing modalities that set the stage for better preparation and ongoing care of the wound bed.
Healthcare Provider Resources
For medical professionals working in the field of wound care or burn treatment, learn more about how Next Science BlastX™ can help your practice and your patients.